Af­ter No­var­tis left, Boehringer bets up to $500M on the field of pre­scrip­tion smart­phone apps

Boehringer In­gel­heim wants in on dig­i­tal ther­a­peu­tics.

The Ger­man phar­ma signed an up to $500 mil­lion col­lab­o­ra­tion with Click Ther­a­peu­tics, one of a hand­ful of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER